Skip to content
DraconiticResearch
Search Sources API
197,787 studies31 sourcesUpdated 1 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

400 Proinflammatory and immune checkpoint responses in bystander tumor cells in an in vitro breast cancer model

  1. 1Faculty of Medicine, Institute of Biochemistry I, Goethe-University Frankfurt, Frankfurt, Germany
  2. 2Universidad de Costa Rica, Montes de Oca, San José, Costa Rica

Related

  1. Safety of concurrent immune checkpoint inhibitor therapy during postoperative radiotherapy for triple-negative breast cancer: A preliminary retrospective analysis
    Gai Liang, Qu Zhang, Mengting Yuan +2
    Oncology LettersPeer-reviewedLicence not statedFull textOncologyPMC
  2. Immune checkpoint inhibitors and chemotherapy versus chemotherapy for early triple‐negative breast cancer
    Ya Gao, Ming Liu, Lun Li +3
    The Cochrane Database of Systematic ReviewsPeer-reviewedLicence not statedFull textGeneral medicinePMC
  3. Immune Responses in Checkpoint Inhibitor–Associated Cardiovascular Immune–Related Adverse Events
    Kerry L. Reynolds, Alexandra-Chloé Villani, Zsófia Dora Drobni +11
    JACC: CardioOncologyPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMCEurope PMC
  4. TALAVE in Breast Cancer: BRCA1/2 Mutation-Dependent Immune Remodeling after PARP Inhibition with Limited Checkpoint Engagement
    F. Lynce, K. Shimada, C. Isaacs +18
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  5. Real-world utilization of immune checkpoint inhibitors in medicare-eligible patients with triple-negative breast cancer in the United States
    Xiaohan Hu, Amin Haiderali, Yezhou Sun +1
    ImmunotherapyPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
BibTeX
@article{mora2026proinflammatory,
  title = {{400 Proinflammatory and immune checkpoint responses in bystander tumor cells in an in vitro breast cancer model}},
  author = {Javier Mora and Fiorella Calderón-Milán and Lucia Figueroa-Protti},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0400},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0400},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 400 Proinflammatory and immune checkpoint responses in bystander tumor cells in an in vitro breast cancer model
AU  - Javier Mora
AU  - Fiorella Calderón-Milán
AU  - Lucia Figueroa-Protti
PY  - 2026
DA  - 2026/11/04
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0400
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0400
SN  - 2051-1426
ER  -